FSA Wealth Management’s VanEck Biotech ETF BBH Stock Holding History

FSA Wealth Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$50.5K	Hold	305	–	–	0.02%	154
2025 Q2	$46.7K	Hold	305	–	–	0.02%	157
2025 Q1	$48K	Hold	305	–	–	0.02%	153
2024 Q4	$47.8K	Buy	305 +2	+0.7%	+$336	0.02%	153
2024 Q3	$53.8K	Buy	+303	New	+$53.8K	0.02%	156
2024 Q1	$50.4K	Hold	303	–	–	0.02%	150
2023 Q4	$50K	Buy	+303	New	+$46.6K	0.02%	141
2021 Q1	–	Sell	-101	Closed	-$17K	–	67
2020 Q4	$17K	Buy	+101	New	+$16.6K	0.01%	219
2020 Q3	–	Sell	-101	Closed	-$16K	–	88
2020 Q2	$16K	Hold	101	–	–	0.01%	213
2020 Q1	$13K	Hold	101	–	–	0.01%	215
2019 Q4	$14K	Buy	+101	New	+$13.3K	0.01%	263

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

FSA Wealth Management's BBH Position: Q3 2025 in Review

FSA Wealth Management held its VanEck Biotech ETF (BBH) position steady in Q3 2025 at 305 shares worth $50.5K. The position accounts for 0.02% of the portfolio, ranked #154.

FSA Wealth Management first reported a position in BBH in Q4 2019 and has held it in 11 quarters since. The position peaked at $53.8K in Q3 2024. 106 funds tracked by Wall St. Rank hold BBH as of Q3 2025.

FSA Wealth Management held 305 shares of VanEck Biotech ETF worth $50.5K as of Q3 2025.
FSA Wealth Management left its VanEck Biotech ETF share count unchanged in Q3 2025.
VanEck Biotech ETF made up 0.02% of FSA Wealth Management's portfolio in Q3 2025, its #154 holding.
FSA Wealth Management first reported a position in VanEck Biotech ETF in Q4 2019 and has held it in 11 quarters since.
FSA Wealth Management's VanEck Biotech ETF position peaked at $53.8K in Q3 2024.
106 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.